Health
Judge deems Trump’s cuts to National Institutes of Health illegal
A federal judge in Boston on Monday said the termination of National Institutes of Health grants for research on diversity-related topics by President Donald Trump’s administration was “void and illegal,” and accused the government of discriminating against racial minorities and LGBT people. U.S. District Judge William Young during a non-jury trial said the NIH violated federal […]
Read More
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
Weight loss syringes of the brands “Wegovy”, “Ozempic” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novo […]
Read More
RFK Jr.’s firing of CDC vaccine panel undermines science, could threaten public health, experts say
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. leaves the stage after discussing the findings of the Centers for Disease Control and Prevention’s (CDC) latest Autism and Developmental Disabilities Monitoring (ADDM) Network survey, at the Department of Health and Human Services in Washington, D.C., U.S., April 16, 2025. Elizabeth Frantz | Reuters […]
Read More
RFK Jr. removes all members of CDC panel advising U.S. on vaccines
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. testifies before the Senate Committee on Appropriations hearing on the Department of Health and Human Services budget, on Capitol Hill in Washington, D.C., U.S., May 20, 2025. Ken Cedeno | Reuters Health and Human Services Secretary Robert F. Kennedy Jr. on Monday said he […]
Read More
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a similar treatment from Sanofi and AstraZeneca. The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead […]
Read More
JPMorgan’s top biotech and pharma picks for the second half
Biopharmaceutical stocks’ underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive order. […]
Read More
How twin sister triathletes doubled down on sports success to raise health-startup millions from investors
During their last year of completing work for doctoral degrees in physiology, twin sisters Michal Mor and Merav Mor started to compete in Ironman triathlon races. The demand for peak fitness led them to the realize the importance of understanding personal metabolism, and the lack of data being collected on it through devices accessible to […]
Read More
It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech
Two graduate students research chemical products in a laboratory in Xiwangzhuang Town, Zaozhuang City, Shandong province of China, on Dec. 26, 2023. Nurphoto | Nurphoto | Getty Images BEIJING — For all the attention on U.S.-China competition in artificial intelligence, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development. […]
Read More
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I’m back in New […]
Read More
Hims & Hers to acquire European telehealth platform in global expansion
The Hims logo arranged on a smartphone in New York, US, on Wednesday, Feb. 12, 2025. Bloomberg | Bloomberg | Getty Images Hims & Hers Health announced Tuesday it will acquire European telehealth platform Zava in its push to expand globally. “We’re excited to take this moment to really accelerate both the European expansion, but […]
Read More